我們已在上線！進一步了解

Nano Dimension

NNDM

市值 US$5.94億

1.41 USD

-0.03

2.08%

收盤時已更新 10月16日下午4:00 EDT

盤前交易

盤後交易

1.40

-0.01

0.71%

1天

-2.08%

5天

-8.44%

1個月

-8.44%

3個月

-4.73%

6個月

-21.67%

今年迄今

-9.62%

1年

-20.34%

5年

-74.41%

10年

-97.93%

關於： Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

員工： 468

科技電腦硬體

新聞

正面

中性

負面

市場情緒 3個月

正面 0%

中性 100%

負面 0%

Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee

WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”).

Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee

Nano Dimension Reports Financial Results for the Second Quarter 2026

Ongoing Strategic Actions Expected to Reduce Annualized Cash Burn by Approximately $25 Million Announced Agreement to Sell MarkForged, Inc. to Stratasys; Transaction Expected to Close in the Second Half of 2026 Completed Sale of AME and Fabrica Product Lines WALTHAM, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd.

Nano Dimension Reports Financial Results for the Second Quarter 2026

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

WALTHAM, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) today announced the appointment of Moshe Rozenbaum as Interim Chief Executive Officer (“CEO”), effective immediately. The Company's Board of Directors (the “Board”) has also appointed Phillip Borenstein as Chairman of the Board.

Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board

Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company's Board of Directors

WALTHAM, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- In connection with the upcoming July 31, 2026, Extraordinary General Meeting of Shareholders (the “July EGM”), Nano Dimension Ltd.

Nano Dimension and Murchinson Announce Agreement to Reconstitute the Company's Board of Directors

Nano Dimension Continues Execution of Cost Savings Initiatives

Enters into Agreement to Terminate Current Corporate Headquarters Lease, Expected to Generate Approximately $25 Million in Cumulative Net Cash Savings Enters into Agreement to Terminate Current Corporate Headquarters Lease, Expected to Generate Approximately $25 Million in Cumulative Net Cash Savings

Nano Dimension Continues Execution of Cost Savings Initiatives

Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign

WALTHAM, Mass.--(BUSINESS WIRE)--Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today issued the following letter to shareholders regarding its upcoming Extraordinary General Meeting (“EGM”) scheduled for July 31, 2026. Nano's Board of Directors (the “Board”) urges shareholders to carefully evaluate its recommendations and vote accordingly. Dear Fellow Shareholders: The upcoming Extraordinary General Meeting centers on a fundamental question: should Murchinson L.

Nano Dimension Board Sets the Record Straight on Murchinson's Self-Interested and Destructive Campaign

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter

Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term sheet with Infinite Epigenetics (“Infinite” or “Infinite Epigenetics”) to form a publicly traded, AI-powered health and diagnostics company.1.

Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

WALTHAM, Mass., June 15, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) today announced it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics ™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale.

Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company

查看新聞排名

價格圖表採用Lightweight Charts™實作